Skip to content

Clinical study of eustachian tube function changes and intervention strategies after radiotherapy for nasopharyngeal carcinoma

Clinical study of eustachian tube function changes and intervention strategies after radiotherapy for nasopharyngeal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061700
Enrollment
Unknown
Registered
2022-06-30
Start date
2022-07-10
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Observation group:Symptomatic treatment
Prevention group:Prophylactic eustachian tube blowing
Treatment group:Therapeutic eustachian tube blowing

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years, male or female; 2. According to the eighth edition of ACJJ (2017 edition), NPC is classified into stage I~IVA; 3. Patients with indications for radiotherapy and planning to receive radiotherapy; 4. NPC patients with normal subjective evaluation and objective examination of eustachian tube function and auditory function before radiotherapy; 5. The subjects voluntarily participated in the study and signed informed consent with good compliance and follow-up.

Exclusion criteria

Exclusion criteria: 1. NPC patients who have received radiotherapy; 2. Eustachian tube dysfunction and hearing impairment confirmed by subjective or objective examination; 3. NPC patients with ear diseases such as tympanic membrane perforation and chronic otitis media; 4. Pregnant or lactating women; 5. Those who have a history of psychotropic drug abuse and cannot get rid of it or have mental disorders; 6. Patients who have also participated in clinical trials of other anticancer drugs; 7. Patients with concomitant diseases that, according to the judgment of the investigator, seriously endanger the patient's safety or affect the patient's ability to complete the study; 8. The researcher considered it unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
TMM eustachian tube function test;acoustic immittance;electric listening test;the seven-item Eustachian Tube Score;the seven-item Eustachian Tube Dysfunction Questionnaire score;Otoendoscopy;Nasal endoscopy;CT examination of eustachian tube;

Countries

China

Contacts

Public ContactYe Jing

The First Affiliated Hospital of Nanchang University

yjholly@ncu.edu.cn+86 13979161109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026